ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Neuromusculoskeletal Medicine OMM

Top Neuromusculoskeletal Medicine OMM Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MUSTAFA HAMMAD MD

Neuromusculoskeletal Medicine OMM

14,353

$1.05M

788
309 are 65+

39%
patients receiving schedule two controlled substances

Avg: 9%

54%
patients receiving schedule three controlled substances

Avg: 9%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 23%

$73
Average prescription price

Avg: $118

KAMEL ELZAWAHRY MD

Neuromusculoskeletal Medicine OMM

6,294

$516K

666
247 are 65+

24%
patients receiving schedule two controlled substances

Avg: 9%

44%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 23%

$82
Average prescription price

Avg: $118

LLOYD GLADDING DO

Neuromusculoskeletal Medicine OMM

3,804

$137K

179
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

31%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$36
Average prescription price

Avg: $118

DAVID HOLMES D.O.

Neuromusculoskeletal Medicine OMM

3,733

$260K

195
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$70
Average prescription price

Avg: $118

TAHER HUSAINY MD

Neuromusculoskeletal Medicine OMM

3,675

$305K

431
352 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 23%

$83
Average prescription price

Avg: $118

JOAN HAYNES M.D.

Neuromusculoskeletal Medicine OMM

2,761

$483K

102
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 23%

$175
Average prescription price

Avg: $118

MOHAMAD SALEH MD

Neuromusculoskeletal Medicine OMM

2,751

$1.17M

415
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

10%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$425
Average prescription price

Avg: $118

CHITTO SARKAR D.O.

Neuromusculoskeletal Medicine OMM

2,331

$225K

170
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 23%

$97
Average prescription price

Avg: $118

CARLOS GANUZA MD

Neuromusculoskeletal Medicine OMM

2,228

$185K

135
18 are 65+

84%
patients receiving schedule two controlled substances

Avg: 9%

23%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 23%

$83
Average prescription price

Avg: $118

VINCENT FARRIER MD

Neuromusculoskeletal Medicine OMM

2,037

$71.5K

155
118 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 23%

$35
Average prescription price

Avg: $118

JAY RUBIN MD

Neuromusculoskeletal Medicine OMM

2,015

$198K

434
340 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 23%

$98
Average prescription price

Avg: $118

RAY LOPEZ M.D.

Neuromusculoskeletal Medicine OMM

1,812

$250K

294
253 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

5%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 23%

$138
Average prescription price

Avg: $118

JOSEPH WILLIAMS M.D.

Neuromusculoskeletal Medicine OMM

1,652

$219K

238
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 23%

$133
Average prescription price

Avg: $118

KAMLESH PATEL M.D.

Neuromusculoskeletal Medicine OMM

1,474

$228K

325
295 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 23%

$155
Average prescription price

Avg: $118

FRANCIS CONIDI D.O,M.S.,P.A.

Neuromusculoskeletal Medicine OMM

1,341

$245K

158
91 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 23%

$182
Average prescription price

Avg: $118

HASSAN BITAR MD

Neuromusculoskeletal Medicine OMM

1,329

$115K

182
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 23%

$86
Average prescription price

Avg: $118

MARK KLAFTER D.O.

Neuromusculoskeletal Medicine OMM

1,123

$540K

181
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 23%

$481
Average prescription price

Avg: $118

RAMON LUGO-SANCHEZ MD

Neuromusculoskeletal Medicine OMM

1,118

$208K

193
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 23%

$186
Average prescription price

Avg: $118

EACHARANGAD JACOB MD

Neuromusculoskeletal Medicine OMM

1,064

$326K

124
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 23%

$307
Average prescription price

Avg: $118

GLENN CHAPMAN D.O.

Neuromusculoskeletal Medicine OMM

647

$132K

75
44 are 65+

33%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 23%

$203
Average prescription price

Avg: $118

IGNACIO CORO MD

Neuromusculoskeletal Medicine OMM

527

$23.1K

146
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 9%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 23%

$44
Average prescription price

Avg: $118

HILDEGARDE GEISSE MD

Neuromusculoskeletal Medicine OMM

241

$8,081

85
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

14%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

6%
prescriptions for brand name drugs

Avg: 23%

$34
Average prescription price

Avg: $118

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank